A citation-based method for searching scientific literature

Heather Wilson, Gennaro Pagano, Edoardo Rosario de Natale, Ayla Mansur, Silvia Paola Caminiti, Sotirios Polychronis, Lefkos T Middleton, Geraint Price, Karl F Schmidt, Roger N Gunn, Eugenii A Rabiner, Marios Politis. Mov Disord 2020
Times Cited: 11







List of co-cited articles
67 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Synaptic Changes in Parkinson Disease Assessed with in vivo Imaging.
David Matuskey, Sule Tinaz, Kyle C Wilcox, Mika Naganawa, Takuya Toyonaga, Mark Dias, Shannan Henry, Brian Pittman, Jim Ropchan, Nabeel Nabulsi,[...]. Ann Neurol 2020
42
54

Imaging synaptic density in the living human brain.
Sjoerd J Finnema, Nabeel B Nabulsi, Tore Eid, Kamil Detyniecki, Shu-Fei Lin, Ming-Kai Chen, Roni Dhaher, David Matuskey, Evan Baum, Daniel Holden,[...]. Sci Transl Med 2016
177
45

Loss of Presynaptic Terminal Integrity in the Substantia Nigra in Early Parkinson's Disease.
Aline Delva, Donatienne Van Weehaeghe, Michel Koole, Koen Van Laere, Wim Vandenberghe. Mov Disord 2020
13
36

Assessing Synaptic Density in Alzheimer Disease With Synaptic Vesicle Glycoprotein 2A Positron Emission Tomographic Imaging.
Ming-Kai Chen, Adam P Mecca, Mika Naganawa, Sjoerd J Finnema, Takuya Toyonaga, Shu-Fei Lin, Soheila Najafzadeh, Jim Ropchan, Yihuan Lu, Julia W McDonald,[...]. JAMA Neurol 2018
147
36

Lower synaptic density is associated with depression severity and network alterations.
Sophie E Holmes, Dustin Scheinost, Sjoerd J Finnema, Mika Naganawa, Margaret T Davis, Nicole DellaGioia, Nabeel Nabulsi, David Matuskey, Gustavo A Angarita, Robert H Pietrzak,[...]. Nat Commun 2019
111
36

The synaptic vesicle cycle.
Thomas C Sudhof. Annu Rev Neurosci 2004
27

Mitochondrial dysfunction and mitophagy in Parkinson's: from familial to sporadic disease.
Brent J Ryan, Selim Hoek, Edward A Fon, Richard Wade-Martins. Trends Biochem Sci 2015
299
27

Synaptic Loss in Primary Tauopathies Revealed by [11 C]UCB-J Positron Emission Tomography.
Negin Holland, P Simon Jones, George Savulich, Julie K Wiggins, Young T Hong, Tim D Fryer, Roido Manavaki, Selena Milicevic Sephton, Istvan Boros, Maura Malpetti,[...]. Mov Disord 2020
13
27

Review: Parkinson's disease: from synaptic loss to connectome dysfunction.
Arianna Bellucci, Nicola Biagio Mercuri, Annalena Venneri, Gaia Faustini, Francesca Longhena, Marina Pizzi, Cristina Missale, PierFranco Spano. Neuropathol Appl Neurobiol 2016
93
27

Mitochondrial Dysfunction in Parkinson's Disease: New Mechanistic Insights and Therapeutic Perspectives.
Jin-Sung Park, Ryan L Davis, Carolyn M Sue. Curr Neurol Neurosci Rep 2018
174
27

PET imaging of synaptic density: A new tool for investigation of neuropsychiatric diseases.
Zhengxin Cai, Songye Li, David Matuskey, Nabeel Nabulsi, Yiyun Huang. Neurosci Lett 2019
31
27

In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease.
Alexander Gerhard, Nicola Pavese, Gary Hotton, Federico Turkheimer, Meltem Es, Alexander Hammers, Karla Eggert, Wolfgang Oertel, Richard B Banati, David J Brooks. Neurobiol Dis 2006
681
27

Synthesis and Preclinical Evaluation of 11C-UCB-J as a PET Tracer for Imaging the Synaptic Vesicle Glycoprotein 2A in the Brain.
Nabeel B Nabulsi, Joël Mercier, Daniel Holden, Stephane Carré, Soheila Najafzadeh, Marie-Christine Vandergeten, Shu-Fei Lin, Anand Deo, Nathalie Price, Martyn Wood,[...]. J Nucl Med 2016
106
27

In vivo imaging of synaptic SV2A protein density in healthy and striatal-lesioned rats with [11C]UCB-J PET.
Majken B Thomsen, Jan Jacobsen, Thea P Lillethorup, Anna C Schacht, Mette Simonsen, Marina Romero-Ramos, David J Brooks, Anne M Landau. J Cereb Blood Flow Metab 2021
6
50

Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats.
Ellis Chika Onwordi, Els F Halff, Thomas Whitehurst, Ayla Mansur, Marie-Caroline Cotel, Lisa Wells, Hannah Creeney, David Bonsall, Maria Rogdaki, Ekaterina Shatalina,[...]. Nat Commun 2020
54
27

An omics-based strategy using coenzyme Q10 in patients with Parkinson's disease: concept evaluation in a double-blind randomized placebo-controlled parallel group trial.
Jannik Prasuhn, Norbert Brüggemann, Nicole Hessler, Daniela Berg, Thomas Gasser, Kathrin Brockmann, Denise Olbrich, Andreas Ziegler, Inke R König, Christine Klein,[...]. Neurol Res Pract 2019
11
27

Serum FGF-21, GDF-15, and blood mtDNA copy number are not biomarkers of Parkinson disease.
Ryan L Davis, Siew L Wong, Phillippa J Carling, Thomas Payne, Carolyn M Sue, Oliver Bandmann. Neurol Clin Pract 2020
6
50


PET imaging reveals early and progressive dopaminergic deficits after intra-striatal injection of preformed alpha-synuclein fibrils in rats.
Majken B Thomsen, Sara A Ferreira, Anna C Schacht, Jan Jacobsen, Mette Simonsen, Cristine Betzer, Poul H Jensen, David J Brooks, Anne M Landau, Marina Romero-Ramos. Neurobiol Dis 2021
10
30

α-Synuclein is localized to mitochondria-associated ER membranes.
Cristina Guardia-Laguarta, Estela Area-Gomez, Cornelia Rüb, Yuhui Liu, Jordi Magrané, Dorothea Becker, Wolfgang Voos, Eric A Schon, Serge Przedborski. J Neurosci 2014
291
18

α-Synuclein binds to the ER-mitochondria tethering protein VAPB to disrupt Ca2+ homeostasis and mitochondrial ATP production.
Sébastien Paillusson, Patricia Gomez-Suaga, Radu Stoica, Daniel Little, Paul Gissen, Michael J Devine, Wendy Noble, Diane P Hanger, Christopher C J Miller. Acta Neuropathol 2017
134
18

Structural and functional features and significance of the physical linkage between ER and mitochondria.
György Csordás, Christian Renken, Péter Várnai, Ludivine Walter, David Weaver, Karolyn F Buttle, Tamás Balla, Carmen A Mannella, György Hajnóczky. J Cell Biol 2006
850
18


There's Something Wrong with my MAM; the ER-Mitochondria Axis and Neurodegenerative Diseases.
Sebastien Paillusson, Radu Stoica, Patricia Gomez-Suaga, Dawn H W Lau, Sarah Mueller, Tanya Miller, Christopher C J Miller. Trends Neurosci 2016
227
18

MAM: more than just a housekeeper.
Teruo Hayashi, Rosario Rizzuto, Gyorgy Hajnoczky, Tsung-Ping Su. Trends Cell Biol 2009
512
18

ER-mitochondria signaling in Parkinson's disease.
Patricia Gómez-Suaga, José M Bravo-San Pedro, Rosa A González-Polo, José M Fuentes, Mireia Niso-Santano. Cell Death Dis 2018
58
18

Serotonin and dopamine transporter PET changes in the premotor phase of LRRK2 parkinsonism: cross-sectional studies.
Daryl J Wile, Pankaj A Agarwal, Michael Schulzer, Edwin Mak, Katherine Dinelle, Elham Shahinfard, Nasim Vafai, Kazuko Hasegawa, Jing Zhang, Jessamyn McKenzie,[...]. Lancet Neurol 2017
52
18

LRRK2 and GBA Variants Exert Distinct Influences on Parkinson's Disease-Specific Metabolic Networks.
Katharina A Schindlbeck, An Vo, Nha Nguyen, Chris C Tang, Martin Niethammer, Vijay Dhawan, Vicky Brandt, Rachel Saunders-Pullman, Susan B Bressman, David Eidelberg. Cereb Cortex 2020
12
18

Imidazoline 2 binding sites reflecting astroglia pathology in Parkinson's disease: an in vivo11C-BU99008 PET study.
Heather Wilson, George Dervenoulas, Gennaro Pagano, Robin J Tyacke, Sotirios Polychronis, Jim Myers, Roger N Gunn, Eugenii A Rabiner, David Nutt, Marios Politis. Brain 2019
20
18

Microglial activation and dopamine terminal loss in early Parkinson's disease.
Yasuomi Ouchi, Etsuji Yoshikawa, Yoshimoto Sekine, Masami Futatsubashi, Toshihiko Kanno, Tomomi Ogusu, Tatsuo Torizuka. Ann Neurol 2005
542
18

Extrastriatal spreading of microglial activation in Parkinson's disease: a positron emission tomography study.
Tatsuhiro Terada, Masamichi Yokokura, Etsuji Yoshikawa, Masami Futatsubashi, Satoshi Kono, Takashi Konishi, Hiroaki Miyajima, Takanori Hashizume, Yasuomi Ouchi. Ann Nucl Med 2016
52
18

Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?
Yaroslau Compta, Laura Parkkinen, Sean S O'Sullivan, Jana Vandrovcova, Janice L Holton, Catherine Collins, Tammaryn Lashley, Constantinos Kallis, David R Williams, Rohan de Silva,[...]. Brain 2011
340
18

Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional study.
Heather Wilson, George Dervenoulas, Gennaro Pagano, Christos Koros, Tayyabah Yousaf, Marina Picillo, Sotirios Polychronis, Athina Simitsi, Beniamino Giordano, Zachary Chappell,[...]. Lancet Neurol 2019
34
18

Microglial activation in Parkinson's disease using [18F]-FEPPA.
Christine Ghadery, Yuko Koshimori, Sarah Coakeley, Madeleine Harris, Pablo Rusjan, Jinhee Kim, Sylvain Houle, Antonio P Strafella. J Neuroinflammation 2017
57
18


Early synaptic dysfunction induced by α-synuclein in a rat model of Parkinson's disease.
Jenny-Ann Phan, Kathrine Stokholm, Justyna Zareba-Paslawska, Steen Jakobsen, Kim Vang, Albert Gjedde, Anne M Landau, Marina Romero-Ramos. Sci Rep 2017
38
18

Dopamine synapse is a neuroligin-2-mediated contact between dopaminergic presynaptic and GABAergic postsynaptic structures.
Motokazu Uchigashima, Toshihisa Ohtsuka, Kazuto Kobayashi, Masahiko Watanabe. Proc Natl Acad Sci U S A 2016
47
18

Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson's disease brains.
Kazuhiro Imamura, Nozomi Hishikawa, Makoto Sawada, Toshiharu Nagatsu, Mari Yoshida, Yoshio Hashizume. Acta Neuropathol 2003
410
18

Microglial inflammation in the parkinsonian substantia nigra: relationship to alpha-synuclein deposition.
Emilie Croisier, Linda B Moran, David T Dexter, Ronald K B Pearce, Manuel B Graeber. J Neuroinflammation 2005
229
18

Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice.
Kelvin C Luk, Victoria Kehm, Jenna Carroll, Bin Zhang, Patrick O'Brien, John Q Trojanowski, Virginia M-Y Lee. Science 2012
18


Serial microPET measures of the metabolic reaction to a microdialysis probe implant.
Wynne K Schiffer, Martine M Mirrione, Anat Biegon, David L Alexoff, Vinal Patel, Stephen L Dewey. J Neurosci Methods 2006
123
18


Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin.
Ira E Clark, Mark W Dodson, Changan Jiang, Joseph H Cao, Jun R Huh, Jae Hong Seol, Soon Ji Yoo, Bruce A Hay, Ming Guo. Nature 2006
18

Role of DJ-1 in the mechanism of pathogenesis of Parkinson's disease.
Ludmila P Dolgacheva, Alexey V Berezhnov, Evgeniya I Fedotova, Valery P Zinchenko, Andrey Y Abramov. J Bioenerg Biomembr 2019
65
18

The c-Abl inhibitor, nilotinib, protects dopaminergic neurons in a preclinical animal model of Parkinson's disease.
Senthilkumar S Karuppagounder, Saurav Brahmachari, Yunjong Lee, Valina L Dawson, Ted M Dawson, Han Seok Ko. Sci Rep 2014
131
18

Mitochondrial dysfunction in Parkinson's disease.
Anindita Bose, M Flint Beal. J Neurochem 2016
315
18

Parkinson's disease-associated human ATP13A2 (PARK9) deficiency causes zinc dyshomeostasis and mitochondrial dysfunction.
Jin-Sung Park, Brianada Koentjoro, David Veivers, Alan Mackay-Sim, Carolyn M Sue. Hum Mol Genet 2014
98
18

Hereditary early-onset Parkinson's disease caused by mutations in PINK1.
Enza Maria Valente, Patrick M Abou-Sleiman, Viviana Caputo, Miratul M K Muqit, Kirsten Harvey, Suzana Gispert, Zeeshan Ali, Domenico Del Turco, Anna Rita Bentivoglio, Daniel G Healy,[...]. Science 2004
18

Multinuclear magnetic resonance spectroscopy for in vivo assessment of mitochondrial dysfunction in Parkinson's disease.
Claire Henchcliffe, Dikoma C Shungu, Xiangling Mao, Chaorui Huang, Melissa J Nirenberg, Bruce G Jenkins, M Flint Beal. Ann N Y Acad Sci 2008
38
18


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.